{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T03:09:09Z","timestamp":1649214549954},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00115-020-00997-8","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T05:03:03Z","timestamp":1600146183000},"page":"955-966","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Restless-legs-Syndrom: ein Update"],"prefix":"10.1007","volume":"91","author":[{"given":"Michael","family":"Bartl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Lucia","family":"Muntean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frie\ufeffde\ufeffri\ufeffke","family":"Sixel-D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"997_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","volume":"15","author":"RP Allen","year":"2014","unstructured":"Allen\u00a0RP, Picchietti\u00a0DL, Garcia-Borreguero\u00a0D et al (2014) Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria\u2014history, rationale, description, and significance. Sleep Med 15:860\u2013873","journal-title":"Sleep Med"},{"key":"997_CR2","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","volume":"165","author":"RP Allen","year":"2005","unstructured":"Allen\u00a0RP, Walters\u00a0AS, Montplaisir\u00a0J et\u00a0al (2005) Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 165:1286\u20131292","journal-title":"Arch Intern Med"},{"issue":"Suppl 18","key":"997_CR3","doi-asserted-by":"publisher","first-page":"S420","DOI":"10.1002\/mds.21589","volume":"22","author":"K Berger","year":"2007","unstructured":"Berger\u00a0K, Kurth\u00a0T (2007) RLS epidemiology\u2014frequencies, risk factors and methods in population studies. Mov Disord 22(Suppl 18):S420\u2013S423","journal-title":"Mov Disord"},{"key":"997_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.sleep.2004.03.006","volume":"5","author":"W Hening","year":"2004","unstructured":"Hening\u00a0W, Walters\u00a0AS, Allen\u00a0RP et\u00a0al (2004) Impact, diagnosis and treatment of restless legs syndrome (RLS) in a\u00a0primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 5:237\u2013246","journal-title":"Sleep Med"},{"key":"997_CR5","unstructured":"Bartl M, Trenkwalder C (2018) Aktuelles zur Diagnostik, Therapie und Patientenversorgung des Restless-Legs-Syndroms. Internist Prax 60:1\u201314"},{"key":"997_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1359105319871632","author":"EG Harrison","year":"2019","unstructured":"Harrison\u00a0EG, Keating\u00a0JL, Morgan\u00a0PE (2019) The experience of living with restless legs syndrome: A qualitative study. J\u00a0Health Psychol. https:\/\/doi.org\/10.1177\/1359105319871632","journal-title":"J Health Psychol"},{"key":"997_CR7","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1212\/WNL.0000000000002542","volume":"86","author":"C Trenkwalder","year":"2016","unstructured":"Trenkwalder\u00a0C, Allen\u00a0R, Hogl\u00a0B et\u00a0al (2016) Restless legs syndrome associated with major diseases: a systematic review and new concept. Neurology 86:1336\u20131343","journal-title":"Neurology"},{"key":"997_CR8","doi-asserted-by":"publisher","first-page":"e001652","DOI":"10.1136\/bmjopen-2012-001652","volume":"2","author":"A Szentkir\u00e1lyi","year":"2012","unstructured":"Szentkir\u00e1lyi\u00a0A, Winter\u00a0AC, Sch\u00fcrks\u00a0M et al (2012) Restless legs syndrome and all-cause mortality in four prospective cohort studies. BMJ Open 2:e1652","journal-title":"BMJ Open"},{"key":"997_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ana.10282","volume":"52","author":"J Winkelmann","year":"2002","unstructured":"Winkelmann\u00a0J, Muller-Myhsok\u00a0B, Wittchen\u00a0HU et al (2002) Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 52:297\u2013302","journal-title":"Ann Neurol"},{"key":"997_CR10","first-page":"1345","volume-title":"Mayo Clinic proceedings","author":"PR Castillo","year":"2006","unstructured":"Castillo\u00a0PR, Kaplan\u00a0J, Lin\u00a0S\u2011C et al (2006) Prevalence of restless legs syndrome among native South Americans residing in coastal and mountainous areas. In: Mayo Clinic proceedings. Elsevier, Amsterdam, S 1345\u20131347"},{"key":"997_CR11","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1002\/mds.22274","volume":"23","author":"T Nomura","year":"2008","unstructured":"Nomura\u00a0T, Inoue\u00a0Y, Kusumi\u00a0M et\u00a0al (2008) Prevalence of restless legs syndrome in a\u00a0rural community in Japan. Mov Disord 23:2363\u20132369","journal-title":"Mov Disord"},{"key":"997_CR12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1474-4422(17)30327-7","volume":"16","author":"B Schormair","year":"2017","unstructured":"Schormair\u00a0B, Zhao\u00a0C, Bell\u00a0S et al (2017) Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a\u00a0meta-analysis. Lancet Neurol 16:898\u2013907","journal-title":"Lancet Neurol"},{"key":"997_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/bs.apha.2019.03.003","volume":"84","author":"AV Salminen","year":"2019","unstructured":"Salminen\u00a0AV, Lam\u00a0DD, Winkelmann\u00a0J (2019) Role of MEIS1 in restless legs syndrome: from GWAS to functional studies in mice. Adv Pharmacol 84:175\u2013184","journal-title":"Adv Pharmacol"},{"key":"997_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fnbeh.2018.00199","volume":"12","author":"S Meneely","year":"2018","unstructured":"Meneely\u00a0S, Dinkins\u00a0ML, Kassai\u00a0M et\u00a0al (2018) Differential dopamine D1 and D3 receptor modulation and expression in the spinal cord of two mouse models of restless legs syndrome. Front Behav Neurosci 12:199","journal-title":"Front Behav Neurosci"},{"key":"997_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jsmc.2015.05.022","volume":"10","author":"RP Allen","year":"2015","unstructured":"Allen\u00a0RP (2015) Restless leg syndrome\/Willis-Ekbom disease pathophysiology. Sleep Med Clin 10:207\u2013214","journal-title":"Sleep Med Clin"},{"key":"997_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.sleep.2016.07.028","volume":"31","author":"JR Connor","year":"2017","unstructured":"Connor\u00a0JR, Patton\u00a0SM, Oexle\u00a0K et\u00a0al (2017) Iron and restless legs syndrome: treatment, genetics and pathophysiology. Sleep Med 31:61\u201370","journal-title":"Sleep Med"},{"key":"997_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1468-1331.2011.03397.x","volume":"18","author":"SM Patton","year":"2011","unstructured":"Patton\u00a0SM, Ponnuru\u00a0P, Snyder\u00a0AM et al (2011) Hypoxia-inducible factor pathway activation in restless legs syndrome patients. Eur J Neurol 18:1329\u20131335","journal-title":"Eur J Neurol"},{"key":"997_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(18)30311-9","volume":"17","author":"C Trenkwalder","year":"2018","unstructured":"Trenkwalder\u00a0C, Allen\u00a0R, Hogl\u00a0B et\u00a0al (2018) Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol 17:994\u20131005","journal-title":"Lancet Neurol"},{"issue":"7","key":"997_CR19","first-page":"160","volume":"17","author":"NB Nordlander","year":"1954","unstructured":"Nordlander, NB (1954) Restless legs. Br J Phys Med 17(7):160\u2013162","journal-title":"Br J Phys Med"},{"key":"997_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2869.2004.00403.x","volume":"14","author":"S Mizuno","year":"2005","unstructured":"Mizuno\u00a0S, Mihara\u00a0T, Miyaoka\u00a0T et\u00a0al (2005) CSF iron, ferritin and transferrin levels in restless legs syndrome. J\u00a0Sleep Res 14:43\u201347","journal-title":"J Sleep Res"},{"key":"997_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.5664\/jcsm.2680","volume":"9","author":"S Mackie","year":"2013","unstructured":"Mackie\u00a0S, Winkelman\u00a0JW (2013) Normal ferritin in a\u00a0patient with iron deficiency and RLS. J\u00a0Clin Sleep Med 9:511\u2013513","journal-title":"J Clin Sleep Med"},{"key":"997_CR22","doi-asserted-by":"publisher","first-page":"j104","DOI":"10.1136\/bmj.j104","volume":"356","author":"D Garcia-Borreguero","year":"2017","unstructured":"Garcia-Borreguero\u00a0D, Cano-Pumarega\u00a0I (2017) New concepts in the management of restless legs syndrome. BMJ 356:j104","journal-title":"BMJ"},{"key":"997_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnagi.2017.00171","volume":"9","author":"S Guo","year":"2017","unstructured":"Guo\u00a0S, Huang\u00a0J, Jiang\u00a0H et\u00a0al (2017) Restless legs syndrome: from pathophysiology to clinical diagnosis and management. Front Aging Neurosci 9:171","journal-title":"Front Aging Neurosci"},{"key":"997_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11910-019-0965-4","volume":"19","author":"P Gonzalez-Latapi","year":"2019","unstructured":"Gonzalez-Latapi\u00a0P, Malkani\u00a0R (2019) Update on restless legs syndrome: from mechanisms to treatment. Curr Neurol Neurosci Rep 19:54","journal-title":"Curr Neurol Neurosci Rep"},{"key":"997_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/01.wnl.0000223316.53428.c9","volume":"67","author":"S Clemens","year":"2006","unstructured":"Clemens\u00a0S, Rye\u00a0D, Hochman\u00a0S (2006) Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67:125\u2013130","journal-title":"Neurology"},{"key":"997_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/mds.26929","volume":"32","author":"B Hogl","year":"2017","unstructured":"Hogl\u00a0B, Stefani\u00a0A (2017) Restless legs syndrome and periodic leg movements in patients with movement disorders: specific considerations. Mov Disord 32:669\u2013681","journal-title":"Mov Disord"},{"key":"997_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1081\/RRS-200029981","volume":"24","author":"KA Neve","year":"2004","unstructured":"Neve\u00a0KA, Seamans\u00a0JK, Trantham-Davidson\u00a0H (2004) Dopamine receptor signaling. J\u00a0Recept Signal Transduct 24:165\u2013205","journal-title":"J Recept Signal Transduct"},{"key":"997_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jsmc.2015.05.006","volume":"10","author":"F Provini","year":"2015","unstructured":"Provini\u00a0F, Chiaro\u00a0G (2015) Neuroimaging in restless legs syndrome. Sleep Med Clin 10:215\u2013226","journal-title":"Sleep Med Clin"},{"key":"997_CR29","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/brain\/awh441","volume":"128","author":"S Von Spiczak","year":"2005","unstructured":"Von Spiczak\u00a0S, Whone\u00a0AL, Hammers\u00a0A et\u00a0al (2005) The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Brain 128:906\u2013917","journal-title":"Brain"},{"key":"997_CR30","unstructured":"Trenkwalder C et\u00a0al (2012) Leitlinie Restless-Legs-Syndrom (RLS) und Periodic Limb Movement Disorder (PLMD). Deutsche Gesellschaft f\u00fcr Neurologie, Kassel, 5\u201313."},{"key":"997_CR31","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1212\/WNL.0000000000002649","volume":"86","author":"A Bauer","year":"2016","unstructured":"Bauer\u00a0A, Cassel\u00a0W, Benes\u00a0H et al (2016) Rotigotine\u2019s effect on PLM-associated blood pressure elevations in restless legs syndrome: an RCT. Neurology 86:1785\u20131793","journal-title":"Neurology"},{"key":"997_CR32","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/sleep\/32.5.589","volume":"32","author":"AS Walters","year":"2009","unstructured":"Walters\u00a0AS, Rye\u00a0DB (2009) Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 32:589\u2013597","journal-title":"Sleep"},{"key":"997_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.sleep.2019.05.013","volume":"63","author":"M Hein","year":"2019","unstructured":"Hein\u00a0M, Lanquart\u00a0JP, Hubain\u00a0P et\u00a0al (2019) Risk of resistant hypertension associated with restless legs syndrome and periodic limb movements during sleep: a\u00a0study on 673 treated hypertensive individuals. Sleep Med 63:46\u201356","journal-title":"Sleep Med"},{"key":"997_CR34","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/mds.20969","volume":"21","author":"K Stiasny-Kolster","year":"2006","unstructured":"Stiasny-Kolster\u00a0K, Kohnen\u00a0R, Moller\u00a0JC et al (2006) Validation of the \u201cL-DOPA test\u201d for diagnosis of restless legs syndrome. Mov Disord 21:1333\u20131339","journal-title":"Mov Disord"},{"key":"997_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","volume":"4","author":"AS Walters","year":"2003","unstructured":"Walters\u00a0AS, Lebrocq\u00a0C, Dhar\u00a0A et\u00a0al (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4:121\u2013132","journal-title":"Sleep Med"},{"issue":"5","key":"997_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.sleep.2008.06.006","volume":"10","author":"H Benes","year":"2009","unstructured":"Benes\u00a0H, Kohnen\u00a0R (2009) Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome\u2010Diagnostic Index (RLS\u2011DI). Sleep Med 10(5):515\u2013523","journal-title":"Sleep Med"},{"key":"997_CR37","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.27260","volume":"33","author":"J Winkelmann","year":"2018","unstructured":"Winkelmann\u00a0J, Allen\u00a0RP, Hogl\u00a0B et al (2018) Treatment of restless legs syndrome: evidence-based review and implications for clinical practice (revised 2017) (section sign). Mov Disord 33:1077\u20131091","journal-title":"Mov Disord"},{"key":"997_CR38","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.sleep.2008.11.003","volume":"10","author":"J Wang","year":"2009","unstructured":"Wang\u00a0J, O\u2019reilly\u00a0B, Venkataraman\u00a0R et al (2009) Efficacy of oral iron in patients with restless legs syndrome and a\u00a0low-normal ferritin: a randomized, double-blind, placebo-controlled study. Sleep Med 10:973\u2013975","journal-title":"Sleep Med"},{"key":"997_CR39","first-page":"35","volume":"01\/2018","author":"HAF Br\u00fcckmann","year":"2018","unstructured":"Br\u00fcckmann\u00a0HAF, Reiner\u00a0D, Stark\u00a0H (2018) Pharmakotherapie des Restless-Legs-Syndroms \u2013 eine detaillierte Betrachtung. Pharmakon 01\/2018:35\u201346","journal-title":"Pharmakon"},{"key":"997_CR40","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/mds.27040","volume":"32","author":"C Trenkwalder","year":"2017","unstructured":"Trenkwalder\u00a0C, Winkelmann\u00a0J, Oertel\u00a0W et\u00a0al (2017) Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: a randomized trial. Mov Disord 32:1478\u20131482","journal-title":"Mov Disord"},{"key":"997_CR41","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1212\/01.WNL.0000138427.83574.A6","volume":"63","author":"M Manconi","year":"2004","unstructured":"Manconi\u00a0M, Govoni\u00a0V, De Vito\u00a0A et\u00a0al (2004) Restless legs syndrome and pregnancy. Neurology 63:1065\u20131069","journal-title":"Neurology"},{"key":"997_CR42","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrneurol.2015.122","volume":"11","author":"C Trenkwalder","year":"2015","unstructured":"Trenkwalder\u00a0C, Winkelmann\u00a0J, Inoue\u00a0Y et al (2015) Restless legs syndrome-current therapies and management of augmentation. Nat Rev Neurol 11:434\u2013445","journal-title":"Nat Rev Neurol"},{"key":"997_CR43","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1212\/WNL.0000000000003388","volume":"87","author":"JW Winkelman","year":"2016","unstructured":"Winkelman\u00a0JW, Armstrong\u00a0MJ, Allen\u00a0RP et\u00a0al (2016) Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology 87:2585\u20132593","journal-title":"Neurology"},{"key":"997_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2165\/00003088-200039040-00001","volume":"39","author":"CM Kaye","year":"2000","unstructured":"Kaye\u00a0CM, Nicholls\u00a0B (2000) Clinical pharmacokinetics of ropinirole. Clin Pharmacokinet 39:243\u2013254","journal-title":"Clin Pharmacokinet"},{"key":"997_CR45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1303646","volume":"370","author":"RP Allen","year":"2014","unstructured":"Allen\u00a0RP, Chen\u00a0C, Garcia-Borreguero\u00a0D et al (2014) Comparison of pregabalin with pramipexole for restless legs syndrome. N\u00a0Engl J Med 370:621\u2013631","journal-title":"N Engl J Med"},{"key":"997_CR46","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S1474-4422(15)00243-4","volume":"14","author":"C Trenkwalder","year":"2015","unstructured":"Trenkwalder\u00a0C, Chaudhuri\u00a0KR, Martinez-Martin\u00a0P et al (2015) Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson\u2019s disease (PANDA): a\u00a0double-blind, randomised, placebo-controlled trial. Lancet Neurol 14:1161\u20131170","journal-title":"Lancet Neurol"},{"key":"997_CR47","doi-asserted-by":"publisher","unstructured":"Romero-Peralta S, Cano-Pumarega I, Garcia-Malo C et al (2019) Treating restless legs syndrome in the context of sleep disordered breathing comorbidity. Eur Respir Rev 28. https:\/\/doi.org\/10.1183\/16000617.0061-2019","DOI":"10.1183\/16000617.0061-2019"},{"key":"997_CR48","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S1474-4422(13)70239-4","volume":"12","author":"C Trenkwalder","year":"2013","unstructured":"Trenkwalder\u00a0C, Benes\u00a0H, Grote\u00a0L et al (2013) Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a\u00a0double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol 12:1141\u20131150","journal-title":"Lancet Neurol"},{"key":"997_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.smrv.2014.10.009","volume":"22","author":"DL Picchietti","year":"2015","unstructured":"Picchietti\u00a0DL, Hensley\u00a0JG, Bainbridge\u00a0JL et al (2015) Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome\/Willis-Ekbom disease during pregnancy and lactation. Sleep Med Rev 22:64\u201377","journal-title":"Sleep Med Rev"},{"key":"997_CR50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jsmc.2015.05.016","volume":"10","author":"C Prosperetti","year":"2015","unstructured":"Prosperetti\u00a0C, Manconi\u00a0M (2015) Restless legs syndrome\/Willis-Ekbom disease and pregnancy. Sleep Med Clin 10:323\u2013329","journal-title":"Sleep Med Clin"},{"key":"997_CR51","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3122\/jabfm.2011.04.100173","volume":"24","author":"M Bayard","year":"2011","unstructured":"Bayard\u00a0M, Bailey\u00a0B, Acharya\u00a0D et\u00a0al (2011) Bupropion and restless legs syndrome: a\u00a0randomized controlled trial. J\u00a0Am Board Fam Med 24:422\u2013428","journal-title":"J Am Board Fam Med"},{"key":"997_CR52","first-page":"53","volume":"01\/2018","author":"M-LFS-D Muntean","year":"2018","unstructured":"Muntean\u00a0M\u2011LFS\u2011D, Trenkwalder\u00a0C (2018) Restless-Legs-Syndrom in der Schwangerschaft. Pharmakon 01\/2018:53\u201358","journal-title":"Pharmakon"},{"key":"997_CR53","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5664\/jcsm.27942","volume":"6","author":"A Oksenberg","year":"2010","unstructured":"Oksenberg\u00a0A (2010) Alleviation of severe restless legs syndrome (RLS) symptoms by cigarette smoking. J\u00a0Clin Sleep Med 6:489\u2013490","journal-title":"J Clin Sleep Med"},{"key":"997_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jns.2016.09.006","volume":"370","author":"S Happe","year":"2016","unstructured":"Happe\u00a0S, Evers\u00a0S, Thiedemann\u00a0C et al (2016) Whole body and local cryotherapy in restless legs syndrome: A randomized, single-blind, controlled parallel group pilot study. J\u00a0Neurol Sci 370:7\u201312","journal-title":"J Neurol Sci"},{"key":"997_CR55","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00415-009-5299-8","volume":"257","author":"B Hogl","year":"2010","unstructured":"Hogl\u00a0B, Garcia-Borreguero\u00a0D, Kohnen\u00a0R et al (2010) Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a\u00a0prospective multi-center study. J\u00a0Neurol 257:230\u2013237","journal-title":"J Neurol"},{"key":"997_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.sleep.2015.10.006","volume":"30","author":"C Trenkwalder","year":"2017","unstructured":"Trenkwalder\u00a0C, Canelo\u00a0M, Lang\u00a0M et al (2017) Management of augmentation of restless legs syndrome with rotigotine: a\u00a01-year observational study. Sleep Med 30:257\u2013265","journal-title":"Sleep Med"},{"key":"997_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","volume":"21","author":"D Garcia-Borreguero","year":"2016","unstructured":"Garcia-Borreguero\u00a0D, Silber\u00a0MH, Winkelman\u00a0JW et al (2016) Guidelines for the first-line treatment of restless legs syndrome\/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a\u00a0combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med 21:1\u201311","journal-title":"Sleep Med"},{"key":"997_CR58","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.sleep.2014.05.011","volume":"15","author":"DL Bliwise","year":"2014","unstructured":"Bliwise\u00a0DL, Zhang\u00a0RH, Kutner\u00a0NG (2014) Medications associated with restless legs syndrome: a\u00a0case-control study in the US Renal Data System (USRDS). Sleep Med 15:1241\u20131245","journal-title":"Sleep Med"},{"key":"997_CR59","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.sleep.2015.08.006","volume":"16","author":"J Schneider","year":"2015","unstructured":"Schneider\u00a0J, Krafft\u00a0A, Manconi\u00a0M et al (2015) Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome. Sleep Med 16:1342\u20131347","journal-title":"Sleep Med"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-020-00997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-020-00997-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-020-00997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T02:22:38Z","timestamp":1631672558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-020-00997-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1007\/s00115-020-00997-8","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"15 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>M.\u00a0Bartl:<\/b> A.\u00a0Finanzielle Interessen: Beratung: DRG(\u201ediagnosis related groups\u201c)-Kodierung, OPS-Kodes Philipps Healthcare.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt, Universit\u00e4tsmedizin G\u00f6ttingen, Klinik f\u00fcr Klinische Neurophysiologie und Klinik f\u00fcr Neurologie | Einfache Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Neurologie, European Restless Legs Syndrome Study Group (EURLSSG), Movement Disorders Society. Mitgliedschaft: Leitlinien-Kommission RLS, DGN (Deutsche Gesellschaft f\u00fcr Neurologie): Leitliniengruppe Restless-Legs-Syndrom. <b>C.\u00a0Trenkwalder:<\/b> A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: M.J.\u00a0Fox, European grant: program Horizon 2020.\u00a0\u2013 Referentenhonorare: UCB, Gruenenthal, Otsuka.\u00a0\u2013 Consultant Expert: Britannia, Roche.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chef\u00e4rztin, Paracelsus-Elena-Klinik, Kassel, Zentrum f\u00fcr Bewegungsst\u00f6rungen, Universit\u00e4tsprofessorin, Abteilung Neurochirurgie, Universit\u00e4tsmedizin G\u00f6ttingen\u00a0| Mitgliedschaften: Movement Disorder Society (IPMDS, Pr\u00e4sidentin), World Sleep Society, International RLS Study Group (IRLSSG), European RLS-Group (Gr\u00fcndungsmitglied), Subgroup der IRLSSG, \u00c4rztlicher Beirat Deutscher RLS e.\u202fV., Deutsche Parkinson Gesellschaft, Leitlinien-Kommission RLS (Vorsitz), DGN (Deutsche Gesellschaft f\u00fcr Neurologie): Leitliniengruppe \u201eRestless-Legs-Syndrom\u201c und \u201eParkinson-Syndrome\u201c, Kommission DRG, Kommission \u201eSchlaf\u201c Fortbildungsakademie, Member AAN (American Academy of Neurology), Sleep Section, M.\u00a0Wilson e.\u202fV. (Gr\u00fcndungsmitglied), DGSM (Deutsche Gesellschaft f\u00fcr Schlafmedizin), AG Tiefe Hirnstimulation. <b>M.\u2011L.\u00a0Muntean: <\/b>A. Finanzielle Interessen: Finanzielle Unterst\u00fctzung f\u00fcr die Publikation eines Papers, UCB, Janunar bis Dezember 2017, institutionell (Paracelsus-Elena-Klinik, Kassel). \u2013 Teilnahme: EAN(European Academy of Neurology)-Kongress, Kongressgeb\u00fchr bezahlt von UCB, Juni 2017. \u2013 B. Nichtfinanzielle Interessen: Ober\u00e4rztin (Neurologie, Schlafmedizin), Paracelsus-Elena-Klinik, Kassel | Mitgliedschaften: Kas, World Sleep Society (WSS), European Restless Legs Study Group (EURLSSG), Deutsche Gesellschaft f\u00fcr Epileptologie (DGfE), Deutsche Gesellschaft f\u00fcr Klinische Neurophysiologie und funktionelle Bildgebung (DGKN), European Academy of Neurology (EAN), International Parkinson and Movement Disorder Society (MDS), International Rapid Eye Movement Sleep Behavior Disorder (RBD) Study Group (IRBDSG). <b>F.\u00a0Sixel-D\u00f6ring: <\/b>A. Finanzielle Interessen: Vortragshonorare: Abbott, Desitin, Gr\u00fcnenthal, Licher MT, Medtronic, STADA Pharm, UCB Pharma, Klinikum Darmstadt, Vitos Klinik f\u00fcr Psychiatrie und Psychotherapie, Erstattung der Reisekosten und Teilnehmergeb\u00fchren: Boston Scientific, Lichter MT, Mundi Pharm. \u2013 Advisory Board: STADA Pharm, UCB Pharma. \u2013 B. Nichtfinanzielle Interessen: Leitende Ober\u00e4rztin, Erm\u00e4chtigungsambulanz f\u00fcr Tiefe Hirnstimulation, Paracelsus-Elena-Klinik, Kassel, Lehrbeauftragte Neurologische Klinik, Philipps-Universit\u00e4t Marburg | Einfache Mitgliedschaften: DGN, Movement Disorder Society, World Sleep Society, DGSM, AG Tiefe Hirnstimulation e.\u202fV. (Gr\u00fcndungsmitglied), International RBD Study Group.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}